Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 20, 2022Dario's third all-equity acquisition in the last 12 months brings cutting edge vision technology to the company's comprehensive digital therapeutics platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market (the Company), announced it has entered into an agreement to purchase all of the right, title and...
Jan 19, 2022New Partnership Expands Dario's Payer Presence with First Contract for Managed MedicaidDarioHealth Corp. (NASDAQ-CM: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has contracted with a large regional health plan (the "Plan") to deliver its...
- Jan 18, 2022Webinar to be held Wednesday, January 19th at 8am ET
DarioHealth Corp. (Nasdaq: DRIO) a leader in the global digital therapeutics (DTx) market, today announced that it will host an investor webinar on navigating the emerging digital health trends in...
Jan 6, 2022Dario's new employer clients include a contract for its full suite of digital therapeutic solutionsDarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced two new contracts today to provide its highly personalized digital therapeutics beginning in...
-
Dec 21, 2021Dario solutions being offered as part of new premier benefits product designed for small business market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage (the "Partner") to sell...
- Dec 2, 2021Dario now counts more than 50 clients across multi-chronic condition platform solutions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the...
- Nov 18, 2021Dario now counts 49 clients across multi-chronic condition platform solutions to date as demand continues to grow
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital...
- Nov 15, 2021Strong B2B new contract growth results in total of 47 signed accounts - 85% achieved in the last two quarters
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 and provided a corporate and commercial...
- Nov 15, 2021Newly created role will support the accelerating growth of Dario as a leader in the digital therapeutics market
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer...
- Nov 11, 2021Dario Now Claims 20 New Contracts in the Last Six Months
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to...